Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Hematology
Study Phase : Discovery
Sponsor : Discovery Life Sciences
Deal Size : Undisclosed
Deal Type : Acquisition
Discovery Life Sciences Acquires ReachBio Research Labs
Details : The Acquisition aims to enhance cell biology capabilities and accelerate assessments of potential new drug targets in hematologic diseases, cell and gene therapy, immunology, oncology, and immuno-oncology.
Brand Name : Undisclosed
Molecule Type : Cell and Gene therapy
Upfront Cash : Undisclosed
April 11, 2023
Lead Product(s) : Undisclosed
Therapeutic Area : Hematology
Highest Development Status : Discovery
Sponsor : Discovery Life Sciences
Deal Size : Undisclosed
Deal Type : Acquisition
LOOKING FOR A SUPPLIER?